Medicine
Monoferric 100 mg/1 mL injection
Monoferric 100 mg/1 mL injection is a prescription medicine containing Ferric derisomaltose for intravenous use, marketed by Pharmacosmos Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20° C to 25°C (68°F to 77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Ferric derisomaltose
- Brand
- Monoferric
- Strength
- 100 mg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 vials of 1 mL
- Marketing authorisation holder
- Pharmacosmos Therapeutics
- Manufacturer
- Pharmacosmos Therapeutics
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20° C to 25°C (68°F to 77°F), excursions permitted to 15° C to 30°C (59°F to 86°F). See the USP controlled room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 January 2020
- Identifiers
- DailyMed set ID 55859d2d-0456-4fa9-b41f-f535accc97dbNDC 73594-9301Application NDA208171
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial in 1 box / 1 mL in 1 vial | 73594-9301-2 | Pharmacosmos Therapeutics | 16 January 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 16 January 2020 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ferric derisomaltose
Clinical summary
Ferric derisomaltose is a prescription medicine indicated for the treatment of iron deficiency anemia (IDA) in adult patients. It is available as injection for intravenous use. MedsAcross supplies Ferric derisomaltose for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ferric derisomaltoseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Monoferric prescribing information (Pharmacosmos Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Monoferric 100 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.